BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 7453849)

  • 1. Relationship between different cell surface markers in chronic lymphocytic leukemia.
    Potomski J; Harłozińska A; Becker M; Noworolska A
    Neoplasma; 1980; 27(3):295-300. PubMed ID: 7453849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rosette formation test with mouse erythrocytes in chronic lymphatic leukosis: correlation with other membrane receptors].
    Rambotti P; Velardi A; Spinozzi F; Falini B; Martelli MF
    Boll Ist Sieroter Milan; 1978 Nov; 57(5):643-9. PubMed ID: 755489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of surface markers in chronic lymphocytic leukemia to acute lymphocytic leukemia.
    Aisenberg AC; Wilkes BM
    Cancer Res; 1981 Nov; 41(11 Pt 2):4810-3. PubMed ID: 6975164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosette formation with mouse erythrocytes. III. Studies in patients with primary immunodeficiency and lymphoproliferative disorders.
    Gupta S; Good RA; Siegal FP
    Clin Exp Immunol; 1976 Nov; 26(2):204-13. PubMed ID: 1068759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A subpopulation of human B lymphocytes that rosette with mouse erythrocytes.
    Forbes IJ; Zalewski PD
    Clin Exp Immunol; 1976 Oct; 26(1):99-107. PubMed ID: 1087215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the human lymphocyte-mouse erythrocyte bond.
    Zalewski PD; Forbes IJ
    Clin Exp Immunol; 1979 Jun; 36(3):536-46. PubMed ID: 314870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation between chronic lymphocytic leukaemia (B-CLL) and non-Hodgkin lymphomas in the leukaemic phase by the mouse red blood cell rosette assay.
    Pecze K; Telek B; Kiss A; Rak K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):446-50. PubMed ID: 2431964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Receptors for murine red blood cells on normal lymphocytes and in chronic lymphocytic leukemia].
    Barboni F; Rovinetti C; Beltrandi E; Andollina A
    Boll Ist Sieroter Milan; 1976; 55(6):481-90. PubMed ID: 1088072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
    Han T; Ozer H; Minowada J
    Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of cell-surface markers in chronic lymphocytic leukaemia (CLL).
    Rak K; Pecze K; Kiss A; Telek B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):294-300. PubMed ID: 6205953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous mouse erythrocyte-rosette formation in chronic lymphocytic leukaemia.
    Kuhlein E; Laurent G; Rigal F; Delsol G; Pris J; Ducos J
    Clin Exp Immunol; 1982 Feb; 47(2):389-95. PubMed ID: 6978782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarities of surface characteristics of neoplastic well-differentiated lymphocytes from solid tissues and from peripheral blood.
    Braylan RC; Jaffe ES; Burbach JW; Frank MM; Johnson RE; Berard CW
    Cancer Res; 1976 May; 36(5):1619-25. PubMed ID: 773529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of the spontaneous rosette formation test with mouse erythrocytes in the complex quantitative analysis of human B-lymphocytes].
    Cheredeev AN; Grunov R; Koval'chuk LV
    Biull Eksp Biol Med; 1980 Jul; 89(7):70-3. PubMed ID: 6967743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the shedding process mouse erythrocyte binding receptors on peripheral blood lymphocytes from healthy donors and patients suffering from chronic lymphocytic leukemia.
    Dobozy A; Hunyadi J; Krizsa F; Kenderessy AS; Simon N
    Exp Hematol; 1980 Jul; 8(6):690-3. PubMed ID: 7202578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic cell features in lymphocytic leukemias: a review.
    Astaldi GC; Topuz U; Guarina L; Astaldi G
    Boll Ist Sieroter Milan; 1975 Jun; 54(2):108-19. PubMed ID: 54182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosette-formation with mouse erythrocytes. II. A marker for human B and non-T lymphocytes.
    Gupta S; Good RA; Siegal FP
    Clin Exp Immunol; 1976 Aug; 25(2):319-27. PubMed ID: 1085238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte-rosette receptor expression by chronic lymphocytic leukemia B lymphocytes.
    Guglielmi P; Preud'homme JL; Brouet JC
    Eur J Immunol; 1983 Aug; 13(8):641-6. PubMed ID: 6603981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts in immunology: Cell-surface markers in lymphoproliferative disease.
    Aisenberg AC
    N Engl J Med; 1981 Feb; 304(6):331-6. PubMed ID: 6969365
    [No Abstract]   [Full Text] [Related]  

  • 19. Surface markers of complement receptor lymphocytes.
    Ross GD; Winchester RJ; Rabellino EM; Hoffman T
    J Clin Invest; 1978 Nov; 62(5):1086-92. PubMed ID: 711854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD5 and CD21 molecules are a functional unit in the cell/substrate adhesion of B-chronic lymphocytic leukemia cells.
    Bergui L; Tesio L; Schena M; Riva M; Malavasi F; Schulz T; Marchisio PC; Caligaris-Cappio F
    Eur J Immunol; 1988 Jan; 18(1):89-96. PubMed ID: 3278912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.